Vitamin D and colon carcinogenesis

Journal of Nutrition

Volumn 134, Issue 12 SUPPL., 2004, Pages

  Harris, Diane M ^a,b   Go, Vay Liang W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcium; Carcinogenesis; Colorectal; Rodent models; Vitamin D; Vitamin D analogs

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NORVITAMIN D3; 1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUOROVITAMIN D3; 1ALPHA,25 DIHYDROXY 16 EN 23 YNE 26,27 HEXAFLUOROCOLECALCIFEROL; 1ALPHA,25 DIHYDROXY 16 ENE 19 NOR 24 OXOVITAMIN D3; 22 OXACALCITRIOL; 24,25 DIHYDROXYCOLECALCIFEROL; ALFACALCIDOL; CALCITRIOL; COLECALCIFEROL DERIVATIVE; SEOCALCITOL; SULINDAC; UNCLASSIFIED DRUG; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RECURRENCE; CELL DIFFERENTIATION; COLON CARCINOGENESIS; COLON POLYP; COLORECTAL CANCER; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIET; DRUG POTENTIATION; HUMAN; INTESTINE CANCER; NONHUMAN; VITAMIN BLOOD LEVEL;

ANIMALIA; RODENTIA;

EID: 9744274548     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.12.3463s     Document Type: Conference Paper

References (112)

1. American Cancer Society [Online] Cancer Facts and Figures (2003) http://www.cancer.org [accessed August 19, 2004].
2. World Cancer Research Fund and American Institute for Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: a global perspective, American Institute for Cancer Research, Washington, DC.
3. Parkin, D. M. & Muir, C. S. (1992) Cancer incidence in five continents. Comparability and quality of data. IARC Sci. Publ. 45-173.
4. Potter, J. D., Slattery, M. L., Bostick, R. M. & Gapstur, S. M. (1993) Colon cancer: a review of the epidemiology. Epidemiol. Rev. 15: 499-545.
5. Potter, J. D. (1996) Nutrition and colorectal cancer. Cancer Causes Control 7: 127-146.
6. Lipkin, M., Reddy, B., Newmark, H. & Lamprecht, S. A. (1999) Dietary factors in human colorectal cancer. Annu. Rev. Nutr. 19: 545-586.
7. Martinez, M. E. & Giovannucci, E. (1997) Diet and the prevention of cancer. Cancer Metastasis Rev. 16: 357-376.
8. Tomeo, C. A., Colditz, G. A., Willett, W. C., Giovannucci, E., Platz, E., Rockhill, B., Dart, H. & Hunter, D. J. (1999) Harvard report on cancer prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control 10: 167-180.
9. Holick, M. F. (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 79: 362-371.
10. Tangpricha, V., Flanagan, J. N., Whitlatch, L. W., Tseng, C. C., Chen, T. C., Holt, P. R., Lipkin, M. S. & Holick, M. F. (2001) 25-Hydroxyvitamin D-1ct-hydroxylase in normal and malignant colon tissue. Lancet 357:1673-1674.
11. 3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287-292.
12. Garland, C. F. & Garland, F. C. (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9: 227-231.
13. Pickle, L. W., Mungiole, M., Jones, G. K. & White, A. A. (1996) Atlas of United States Mortality [Online]. National Center for Health Statistics, Hyattsville, MD, http://www.cdc.gov/nchs/data/gis/atmapcc.pdf [accessed July 12, 2004].
14. Martinez, M. E. & Willett, W. C. (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol. Biomarkers Prev, 7: 163-168.
15. Lipkin, M. & Newmark, H. (1995) Calcium and the prevention of colon cancer. J. Cell. Biochem. 22 (suppl.): 65-73.
16. Platz, E. & Giovannucci, E. (1999) Vitamin D and calcium in colorectal and prostate cancers. In: Nutritional Oncology (Heber, D., Blackburn, G. L. & Go, V.L.W., eds.), pp. 223-252. Academic Press, San Diego, CA.
17. Chia, V. & Newcomb, P. A. (2004) Calcium and colorectal cancer: some questions remain. Nutr. Rev. 62: 115-120.
18. Ingles, S. A., Wang, J., Coetzee, G. A., Lee, E. R., Frankl, H. D. & Haile, R. W. (2001) Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 12: 607-614.
19. Grau, M. V., Baron, J. A., Sandler, R. S., Haile, R. W., Beach, M. L., Church, T. R. & Heber, D. (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J. Natl. Cancer Inst. 95: 1765-1771.
20. Peters, U., McGlynn, K. A., Chatterjee, N., Gunter, E., Garcia-Closas, M., Rothman, N. & Sinha, R. (2001) Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 10: 1267-1274.
21. Holt, P. R., Arber, N., Halmos, B., Forde, K., Kissileff, H., McGlynn, K. A., Moss, S. F., Kurihara, N., Fan, K., et al. (2002) Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol. Biomarkers Prev. 11: 113-119.
22. Cho, E., Smith-Warner, S. A., Spiegelman, D., Beeson, W. L., van den Brandt, P. A., Colditz, G. A., Folsom, A. R., Fraser, G. E., Freudenheim, J. L., et al. (2004) Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J. Natl. Cancer Inst. 96: 1015-1022.
23. Kleibeuker, J. H., van der Meer, R. & de Vries, E. G. (1995) Calcium and vitamin D: possible protective agents against colorectal cancer? Eur. J. Cancer 31A: 1081-1084.
24. Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., et al. (1999) Calcium supplements and colorectal adenomas. Polyp Prevention Study Group. Ann. N.Y. Acad. Sci. 889: 138-145.
25. Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., et al. (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N. Engl. J. Med. 340: 101-107.
26. Vanchieri, C. (2004) Studies shedding light on vitamin D and cancer. J. Natl. Cancer Inst. 96: 735-736.
27. Greenwald, P., Kelloff, G. J., Boone, C. W. & McDonald, S. S. (1995) Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 4: 691-702.
28. Fearon, E. R. & Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
29. Fodde, R., Smits, R. & Clevers, H. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1: 55-67.
30. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev. 14: 1837-1851.
31. Reddy, B. S. (2004) Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Environ. Mol. Mutagen. 44: 26-35.
32. 3. Carcinogenesis 9: 187-190.
33. Beaty, M. M., Lee, E. Y. & Glauert, H. P. (1993) Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J. Nutr. 123: 144-152.
34. Sitrin, M. D., Halline, A. G., Abrahams, C. & Brasitus, T. A. (1991) Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res. 51: 5608-5613.
35. Llor, X., Jacoby, R. F., Teng, B. B., Davidson, N. O., Sitrin, M. D. & Brasitus, T. A. (1991) K-ras mutations in 1,2-dimethylhydrazine-induced colonic tumors: effects of supplemental dietary calcium and vitamin D deficiency. Cancer Res. 51: 4305-4309.
36. 3 in rat colon carcinogenesis. Nutr. Cancer 38: 65-73.
37. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis 13: 2293-2298.
38. 3 (cholecalciferol) on colon carcinogenesis induced by 1,2-dimethylhydrazine in male Fischer 344 rats. Nutr. Cancer 19: 113-124.
39. 3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int. J. Cancer 81: 730-733.
40. Moser, A. R., Pitot, H. C. & Dove, W. F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
41. Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B., Breukel, C., Alt, E., Lipkin, M. & Khan, P. M. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. U.S.A. 91: 8969-8973.
42. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. & Taketo, M. (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. U.S.A. 92: 4482-4486.
43. Bilger, A., Shoemaker, A. R., Gould, K. A. & Dove, W. F. (1996) Manipulation of the mouse germline in the study of Min-induced neoplasia. Semin. Cancer Biol. 7: 249-260.
44. Min: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 31A: 1061-1064.
45. Chiu, C. H., McEntee, M. F. & Whelan, J. (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res. 57: 4267-4273.
46. min mouse. Cancer Res. 62: 741-746.
47. Newmark, H. L., Wargovich, M. J. & Bruce, W. R. (1984) Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J. Natl. Cancer Inst. 72: 1323-1325.
48. min mouse: effects of levels of dietary calcium and altered vitamin D homeostasis. Dig. Dis. Sci. 48: 870-876.
49. Yang, K., Edelmann, W., Fan, K., Lau, K., Leung, D., Newmark, H., Kucherlapati, R. & Lipkin, M. (1998) Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Res. 58:5713-5717.
50. Yang, W. C., Mathew, J., Velcich, A., Edelmann, W., Kucherlapati, R., Lipkin, M., Yang, K. & Augenlicht, L. H. (2001) Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res. 61: 565-569.
51. Newmark, H. L., Lipkin, M. & Maheshwari, N. (1990) Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J. Natl. Cancer Inst. 82: 491-496.
52. Newmark, H. L., Lipkin, M. & Maheshwari, N. (1991) Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). Am. J. Clin. Nutr. 54: 209S-214S.
53. Richter, F., Newmark, H. L., Richter, A., Leung, D. & Lipkin, M. (1995) Inhibition of Western-diet induced hyperproliferation and hyperplasia in mouse colon by two sources of calcium. Carcinogenesis 16: 2685-2689.
54. Risio, M., Lipkin, M., Newmark, H., Yang, K., Rossini, F. P., Steete, V. E., Boone, C. W. & Kelloff, G. J. (1996) Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res. 56: 4910-4916.
55. Newmark, H. L., Yang, K., Lipkin, M., Kopelovich, L., Liu, Y., Fan, K. & Shinozaki, H. (2001) A Western-style diet induces benign and malignant neoplasms in the colon of normal C57B1/6 mice. Carcinogenesis 22: 1871-1875.
56. 3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon Carcinogenesis model. Int. J. Oncol. 16: 1249-1254.
57. 3. Jpn. J. Cancer Res. 88: 1052-1062.
58. 3 in N,N′-dimethylhydrazine-induced rat colon Carcinogenesis. Carcinogenesis 21:173-178.
59. 3 suppresses colonic tumorigenesis induced by repetitive intrarectal injection of N-methyl-N-nitrosourea in rats. Cancer Lett. 55:149-152.
60. 3. Carcinogenesis 6: 2091-2097.
61. 3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res. 55: 3050-3054.
62. 3 inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol. Biomarkers Prev. 11: 1653-1662.
63. 3 and its synthetic analogue, 1-α,25-dihydroxy-16-ene-23yne- 26,27-hexafluoro-19-nor-cholecalciferol (Ro 25-6760), on a human colon cancer xenograft. Clin. Cancer Res. 4: 2869-2876.
64. 3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model. Dis. Colon Rectum 40:317-321.
65. Gulliford, T., English, J., Colston, K. W., Menday, P., Moller, S. & Coombes, R. C. (1998) A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br. J. Cancer 78: 6-13.
66. Dalhoff, K., Dancey, J., Astrup, L, Skovsgaard, T., Hamberg, K. J., Lofts, F. J., Rosmorduc, O., Erlinger, S., Bach, H. J., et al. (2003) A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br. J. Cancer 89: 252-257.
67. Evans, T. R., Colston, K. W., Lofts, F. J., Cunningham, D., Anthoney, D. A., Gogas, H., de Bono, J. S., Hamberg, K. J., Skov, T. & Mansi, J. L. (2002) A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br. J. Cancer 86: 680-685.
68. 3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res. 7: 817-821.
69. Glinghammar, B. & Rafter, J. (1999) Carcinogenesis in the colon: interaction between luminal factors and genetic factors. Eur. J. Cancer Prev. 9 (suppl. 1): S87-S94.
70. 3. Cancer Res. 54: 4057-4064.
71. Thomas, M. G., Tebbutt, S. & Williamson, R.C. (1992) Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 33: 1660-1663.
72. Brenner, R. V., Shabahang, M., Schumaker, L. M., Nauta, R. J., Uskokovic, M. R., Evans, S. R. & Buras, R. R. (1995) The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells. Cancer Lett. 92: 77-82.
73. Buras, R. R., Schumaker, L. M., Davoodi, F., Brenner, R. V., Shabahang, M., Nauta, R. J. & Evans, S. R. (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res. Treat 31: 191-202.
74. 3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. J. Cell Biochem. 66: 413-425.
75. 3 analogs on clonal proliferation of human prostate cancer cell lines. Prostate 31: 77-83.
76. 3 and its fluorinated analogues. Cancer Res. 44: 5624-5628.
77. Thomas, M. G. (1995) Luminal and humoral influences on human rectal epithelial cytokinetics. Ann. R. Coll. Surg. Engl. 77: 85-89.
78. 3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium. Biochem. Biophys. Res. Commun. 179: 57-62.
79. 3 receptors in established human cancer cell lines in culture. Cancer Res. 42: 1116-1119.
80. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res. 53: 3712-3718.
81. Sheinin, Y., Kaserer, K., Wrba, F., Wenzl, E., Kriwanek, S., Peterlik, M. & Cross, H. S. (2000) In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch. 437: 501-507.
82. Kallay, E., Pietschmann, P., Toyokuni, S., Bajna, E., Hahn, P., Mazzucco, K., Bieglmayer, C., Kato, S. & Cross, H. S. (2001) Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22: 1429-1435.
83. Lamprecht, S. A. & Lipkin, M. (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer 3: 601-614.
84. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K. & Kato, S. (1999) Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283: 1317-1321.
85. 3: implications in cell growth and differentiation. Endocr. Rev. 23: 763-786.
86. Yanagi, Y., Suzawa, M., Kawabata, M., Miyazono, K., Yanagisawa, J. & Kato, S. (1999) Positive and negative modulation of vitamin D receptor function by transforming growth factor-β signaling through Smad proteins. J. Biol. Chem. 274: 12971-12974.
87. 3. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G864-G874.
88. Ylikomi, T., Laaksi, I., Lou, Y. R., Martikainen, P., Miettinen, S., Pennanen, P., Purmonen, S., Syvala, H., Vienonen, A. & Tuohimaa, P. (2002) Antiproliferative action of vitamin D. Vitam. Horm. 64: 357-406.
89. 3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21(Waf1), and p27(Kip1). Endocrinology 141: 3931-3939.
90. 1-S phase-controlling machinery. Mol. Endocrinol. 15: 1370-1380.
91. 3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT-29 cells: possible implication of intracellular calcium. Cancer Lett. 97: 99-106.
92. 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 60: 2304-2312.
93. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154:369-387.
94. Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R. & Mangelsdorf, D. J. (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296: 1313-1316.
95. Heaney, R. P. (2003) Long-latency deficiency disease: insights from calcium and vitamin D. Am. J. Clin. Nutr. 78: 912-919.
96. Stokstad, E. (2003) Nutrition. The vitamin D deficit. Science 302: 1886-1888.
97. Thomas, M. K., Lloyd-Jones, D. M., Thadhani, R. I., Shaw, A. C., Deraska, D. J., Kitch, B. T., Vamvakas, E. C., Dick, I. M., Prince, R. L. & Finkelstein, J. S. (1998) Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338: 777-783.
98. Tangpricha, V., Pearce, E. N., Chen, T. C. & Holick, M. F. (2002) Vitamin D insufficiency among free-living healthy young adults. Am. J. Med. 112: 659-662.
99. Chiu, K. C., Chu, A., Go, V. L. & Saad, M. F. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79: 820-825.
100. Nesby-O'Dell, S., Scanlon, K. S., Cogswell, M. E., Gillespie, C., Hollis, B. W., Looker, A. C., Allen, C., Doughertly, C., Gunter, E. W. & Bowman, B. A. (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 76: 187-192.
101. Holick, M. F. (1998) Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos. Int. 8 (Suppl. 2): S24-S29.
102. Food and Nutrition Board, Institute of Medicine. (1997) Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, National Academy Press, Washington, DC.
103. Holick, M. F., Matsuoka, L. Y. & Wortsman, J. (1989) Age, vitamin D, and solar ultraviolet. Lancet 2: 1104-1105.
104. Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z. & Holick, M. F. (2000) Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 72: 690-693.
105. Parikh, S. J., Edelman, M., Uwaifo, G. I., Freedman, R. J., Semega-Janneh, M., Reynolds, J. & Yanovski, J. A. (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J. Clin. Endocrinol. Metab. 89: 1196-1199.
106. Jacobs, E. T., Martinez, M. E. & Alberts, D. S. (2003) Research and public health implications of the intricate relationship between calcium and vitamin D in the prevention of colorectal neoplasia. J. Natl. Cancer Inst. 95: 1736-1737.
107. Chen, T. C., Shao, A., Heath, H., III & Holick, M. F. (1993) An update on the vitamin D content of fortified milk from the United States and Canada. N. Engl. J. Med. 329: 1507.
108. Holick, M. F., Shao, Q., Liu, W. W. & Chen, T. C. (1992) The vitamin D content of fortified milk and infant formula. N. Engl. J. Med. 326: 1178-1181.
109. Tanner, J. T., Smith, J., Defibaugh, P., Angyal, G., Villalobos, M., Bueno, M. P., McGarrahan, E. T., Wehr, H. M., Muniz, J. F., et al. (1988) Survey of vitamin content of fortified milk. J. Assoc. Off. Anal. Chem. 71: 607-610.
110. Moore, C., Murphy, M. M., Keast, D. R. & Holick, M. F. (2004) Vitamin D intake in the United States. J. Am. Diet. Assoc. 104: 980-983.
111. Tangpricha, V., Koutkia, P., Rieke, S. M., Chen, T. C., Perez, A. A. & Holick, M. F. (2003) Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am. J. Clin. Nutr. 77: 1478-1483.
112. Newmark, H. L., Heaney, R. P. & Lachance, P. A. (2004) Should calcium and vitamin D be added to the current enrichment program for cereal-grain products? Am. J. Clin. Nutr. 80: 264-270.